BWAY - Brainsway Ltd.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 16

Open

$ 15.82

Bid

$ 15.33 x 17

Ask

$ 16.24 x 135

Day's Range

$ 15.36 - $ 16.09

52 Week Range

$ 7.84 - $ 17.00

Volume

85,313

Average Volume

Market Cap

301.01M

Beta (5Y Monthly)

$ 1.27

PE Ratio (TTM)

$ 103.05

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

BrainsWay Announces FDA Granted Expansion ...
09/16/2025 12:33:12

HC Wainwright & Co. Reiterates Buy on Brai...
08/25/2025 11:03:05

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $17 price tar...

BrainsWay Announces Strategic Investment I...
08/21/2025 13:34:33

Neurolief, a pioneering brain stimulation company specializing in non-invasive neuromodulation therapies, today announced a st...

BrainsWay Invests $2.3M In Axis Mental Hea...
08/20/2025 11:38:37

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

Breaking Down BrainsWay: 4 Analysts Share ...
08/14/2025 19:01:33

Northland Capital Markets Maintains Outper...
08/14/2025 18:05:37

Northland Capital Markets analyst Carl Byrnes maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price targe...

HC Wainwright & Co. Maintains Buy on Brain...
08/14/2025 11:24:04

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

BrainsWay Raises FY2025 Sales Guidance fro...
08/13/2025 11:32:29

BrainsWay (NASDAQ:BWAY) raises FY2025 sales outlook from $49.000 million-$51.000 million to $50.000 million-$52.000 million.

BrainsWay Q2 EPS $0.05, Inline, Sales $12....
08/13/2025 11:32:03

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.05 per share which met the analyst consensus estimate. This is a 150 ...

Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

HC Wainwright & Co. Reiterates Buy on Brai...
06/12/2025 11:08:13

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $16 price tar...

BrainsWay Sees Comparable Results Between ...
06/11/2025 11:33:27

HC Wainwright & Co. Reiterates Buy on Brai...
06/09/2025 12:27:18

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $16 price tar...

Brainsway Enters Into Strategic Equity Fin...
06/04/2025 11:35:21

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

12 Health Care Stocks Moving In Friday's P...
05/23/2025 12:08:30

BrainsWay Affirms FY2025 Sales Guidance of...
05/13/2025 11:32:21

BrainsWay (NASDAQ:BWAY) affirms FY2025 sales outlook from $49.00 million-$51.00 million to $49.00 million-$51.00 million vs $17...

BrainsWay Q1 EPS $0.02 Misses $0.09 Estima...
05/13/2025 11:31:54

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.09 by ...

Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

HC Wainwright & Co. Reiterates Buy on Brai...
03/12/2025 11:40:00

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $16 price tar...

BrainsWay Expects 2025 Sales Of $49M-$51M,...
03/11/2025 11:34:39